
Theratechnologies THTX
Geschäftsbericht 2024
hinzugefügt 21.02.2026
Theratechnologies EBITDA per Share 2011-2026 | THTX
EBITDA per Share Jährlich Theratechnologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -0.33 | -0.23 | -0.11 | -0.05 | -0.0918 | 0.068 | 0.071 | -0.144 | -0.0698 | -0.234 | -0.307 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.071 | -0.33 | -0.13 |
EBITDA per Share anderer Aktien in der Pharmaeinzelhändler
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
Graybug Vision
GRAY
|
-1.54 | - | -11.23 % | $ 9.65 M | ||
|
Apellis Pharmaceuticals
APLS
|
0.45 | $ 19.87 | -1.44 % | $ 2.51 B | ||
|
Aptorum Group Limited
APM
|
0.34 | $ 0.82 | 3.61 % | $ 4.47 M | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | ||
|
AbCellera Biologics
ABCL
|
-0.67 | $ 3.66 | -1.43 % | $ 1.09 B | ||
|
Athersys
ATHX
|
-0.382 | - | 3.77 % | $ 22.4 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-1.52 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
-3.34 | $ 163.94 | -0.07 % | $ 8.16 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-2.28 | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
0.38 | - | -4.8 % | $ 255 M | ||
|
Burford Capital Limited
BUR
|
1.11 | $ 8.43 | -1.4 % | $ 1.39 B | ||
|
BridgeBio Pharma
BBIO
|
-2.7 | $ 65.12 | 0.91 % | $ 12.5 B | ||
|
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | ||
|
CymaBay Therapeutics
CBAY
|
-0.95 | - | - | $ 3.45 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Avid Bioservices
CDMO
|
-0.12 | - | - | $ 789 M | ||
|
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M | ||
|
BioMarin Pharmaceutical
BMRN
|
2.55 | $ 59.06 | 0.91 % | $ 11.3 B | ||
|
Checkpoint Therapeutics
CKPT
|
-1.42 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-2.67 | - | -16.75 % | $ 25.8 M | ||
|
Alpine Immune Sciences
ALPN
|
-1.72 | - | - | $ 2.17 B | ||
|
Clovis Oncology
CLVS
|
-1.88 | - | -7.23 % | $ 13 M | ||
|
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | ||
|
Checkmate Pharmaceuticals
CMPI
|
-2.84 | - | - | $ 231 M | ||
|
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M | ||
|
CTI BioPharma Corp.
CTIC
|
-0.68 | - | - | $ 1.2 B | ||
|
CohBar
CWBR
|
-4.24 | - | -15.44 % | $ 2.2 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
-0.54 | - | -5.98 % | $ 34.1 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-0.54 | - | -4.36 % | $ 27 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
-2.46 | - | - | $ 2.18 B | ||
|
Cabaletta Bio
CABA
|
-62.7 | $ 3.25 | 0.03 % | $ 3.8 M | ||
|
Capricor Therapeutics
CAPR
|
-0.86 | $ 25.35 | -1.92 % | $ 679 M | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
Codexis
CDXS
|
-0.73 | $ 0.97 | -1.14 % | $ 71.2 M | ||
|
Corvus Pharmaceuticals
CRVS
|
-0.48 | $ 17.25 | -1.6 % | $ 828 M | ||
|
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Certara
CERT
|
0.6 | $ 7.44 | 2.69 % | $ 1.19 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
Coherus BioSciences
CHRS
|
-2.12 | $ 1.71 | 3.33 % | $ 161 M | ||
|
Entasis Therapeutics Holdings
ETTX
|
-1.2 | - | - | $ 105 M | ||
|
Evofem Biosciences
EVFM
|
-3.6 | - | 7.55 % | $ 38.1 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M |